Status:
RECRUITING
Patient Registry of Blind Subjects With Sleep-related Problems
Lead Sponsor:
Vanda Pharmaceuticals
Conditions:
Sleep-wake Disorder in Blind Individuals
Eligibility:
All Genders
Brief Summary
Non-24-hour sleep-wake disorder (Non-24) is a condition experienced primarily by totally blind individuals that results in abnormal night sleep patterns and chronic daytime sleepiness. This is a resea...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects or legal guardians must be at least 18 years of age to participate in the telephone survey. Parents or legal guardians may represent children from 0 through 17 years who meet the following criteria.
- Subjects must be blind.
- Subjects must have some self-described problem with sleep or daytime sleepiness.
Exclusion
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2030
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01195558
Start Date
April 1 2010
End Date
April 1 2030
Last Update
June 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanda Pharmaceuticals
Washington D.C., District of Columbia, United States, 20037